More to come…
Frank Bennett, Ionis, USA
Roxana O Carare, Southampton, UK
Preclinical evaluation of a novel anti-tau vaccine based on UBITh peptide technology
Don Cleveland, UC San Diego, USA
Ilse Dewachter, Hasselt, Belgium
Michel Goedert, Cambridge, UK
Jürgen Götz, Brisbane, Australia
Tau in Alzheimer’s disease – from pathomechanistic studies to therapeutic ultrasound as a treatment modality
Bernard Hanseeuw, Louvain, Belgium
Eckhard Mandelkow, Germany
Pierre Maquet, Liège, Belgium
Ana Melo de Farias, Brazil & France
Alzheimer’s risk gene PTK2B effects TAU phosphorylation in human induced neurons
Tim Miller, MO, USA
Leonard Petrucelli, FL, USA
TMEM106b and tau
Naruhiko Sahara, Inage, Chiba, Japan
Dissecting mechanisms of tauopathy using in vivo multimodal imaging techniques on tauopathy mouse models
Wiep Scheper, Amsterdam, NL
Maria Grazia Spillantini, Cambridge, UK
Patrik Verstreken, Leuven, Belgium
Susanne Wegmann, Berlin, Germany